Mark J. Ricciardi
Expertise in
23
conditions

Dr. Mark J. Ricciardi

Interventional Cardiology | Cardiology
2050 Pfingsten Rd., Suite 330, 
Glenview, IL 
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
23
conditions
2050 Pfingsten Rd., Suite 330, 
Glenview, IL 

Overview

Mark Joseph Ricciardi, MD, a specialist in cardiology at Endeavor Health, focuses on the treatment of coronary artery and structural heart disease. He performs advanced procedures including transcatheter aortic and mitral valve replacement and repair. Dr. Ricciardi provides catheter-based care for patients with valvular and complex cardiac conditions.

Dr. Ricciardi is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Mitral Valve Regurgitation, Aortic Valve Stenosis, Coronary Heart Disease, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Ricciardi is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 56 peer reviewed articles and participating in 14 clinical trials. Dr. Ricciardi is currently accepting new patients.

Specialties

Interventional Cardiology
Cardiology

Licenses

Internal Medicine in IL

Board Certifications

American Board Of Internal Medicine

Fellowships

University of Michigan Health System, Cardiovascular Medicine Fellowship, Clinical Cardiology, 1997
University of Michigan Health System, Interventional Cardiology Fellowship, Interventional Cardiology, 1998

Hospital Affiliations

Swedish Hospital
Northshore University Healthsystem - Evanston Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Endeavor Health Medical Group
2050 Pfingsten Rd., Suite 330, Glenview, IL 60026

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

14 Clinical Trials

Multicenter Registry of Chronic Total Occlusion Interventions
Multicenter Registry of Chronic Total Occlusion Interventions
Enrollment Status: Recruiting
Publish Date: August 19, 2026
The Safety and Effectiveness of the Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA (SAPIEN 3/Ultra/RESILIA) Valve in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification Who Are Not Candidates for Standard Mitral Valve Surgery.
The Safety and Effectiveness of the Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA (SAPIEN 3/Ultra/RESILIA) Valve in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification Who Are Not Candidates for Standard Mitral Valve Surgery.
Enrollment Status: Recruiting
Publish Date: January 13, 2026
Intervention Type: Device
Study Phase: Not Applicable
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial
Enrollment Status: Active_not_recruiting
Publish Date: July 28, 2026
Intervention Type: Device
Study Phase: Not Applicable
Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
Edwards PASCAL TrAnScatheter Valve RePair System in Tricuspid Regurgitation (CLASP TR) Early Feasibility Study
Enrollment Status: Completed
Publish Date: July 10, 2026
Intervention Type: Device
Study Phase: Not Applicable
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Edwards PASCAL TrAnScatheter Valve RePair System Pivotal Clinical Trial (CLASP IID/IIF): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Mitral Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System Compared to Abbott MitraClip in Patients With Mitral Regurgitation
Enrollment Status: Active_not_recruiting
Publish Date: July 08, 2026
Intervention Type: Device
Study Phase: Not Applicable
Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
Enrollment Status: Suspended
Publish Date: June 03, 2026
Intervention Type: Device, Drug
Study Phase: Not Applicable
Clinical Study of Edwards Cardioband FIT Valve Repair System
Clinical Study of Edwards Cardioband FIT Valve Repair System
Enrollment Status: Active_not_recruiting
Publish Date: May 08, 2026
Intervention Type: Device
Study Phase: Not Applicable
A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System
A Post-Market Study Assessment of the Safety and Performance of the MitraClip G4 System
Enrollment Status: Active_not_recruiting
Publish Date: July 11, 2025
Intervention Type: Device
Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal
Clinical Trial to Evaluate Cardiovascular Outcomes In Patients Treated With the Tricuspid Valve Repair System Pivotal
Enrollment Status: Active_not_recruiting
Publish Date: December 19, 2024
Intervention Type: Device
Study Phase: Not Applicable
Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure
Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Device
Study Phase: Not Applicable
View 8 Less Clinical Trials

56 Total Publications

Real-world analysis of outcomes of patients undergoing coronary intravascular lithotripsy versus atherectomy for calcified coronary artery disease: findings from the TriNetX database.
Real-world analysis of outcomes of patients undergoing coronary intravascular lithotripsy versus atherectomy for calcified coronary artery disease: findings from the TriNetX database.
Journal: The Journal of invasive cardiology
Published: May 04, 2026
Similar Doctors
Expertise in
23
conditions
Dr. Amir Darki
Interventional Cardiology
Expertise in
23
conditions
Dr. Amir Darki
Interventional Cardiology
Referral may be required
Before you request

Loyola University Medical Center

2160 S 1st Ave, 
Maywood, IL 
 (16.1 miles away)
888-584-7888
Languages Spoken:
English, Farsi
See accepted insurances
Accepting New Patients
Offers Telehealth

Amir Darki is an Interventional Cardiologist practicing medicine in Maywood, Illinois. Dr. Darki is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Pulmonary Embolism, Saddle Pulmonary Embolism, Heart Attack, Embolectomy, and Thrombectomy. Dr. Darki is currently accepting new patients.

Expertise in
21
conditions
Dr. Justin P. Levisay
Interventional Cardiology | Cardiology
Expertise in
21
conditions
Dr. Justin P. Levisay
Interventional Cardiology | Cardiology
Referral may be required
Before you request

Endeavor Health Medical Group

2050 Pfingsten Rd., Suite 330, 
Glenview, IL 
 (0.1 miles away)
847-570-2450
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Justin P. Levisay, MD, a specialist in cardiovascular disease and interventional cardiology at Endeavor Health, focuses on structural heart disease and peripheral interventions. He treats coronary artery disease, valvular conditions and peripheral vascular disease. Dr. Levisay performs catheter-based procedures including TAVR, valvuloplasty and mitral interventions. Dr. Levisay is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Mitral Valve Regurgitation, Coronary Heart Disease, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement. Dr. Levisay is board certified in American Board Of Internal Medicine. Dr. Levisay is currently accepting new patients.

Expertise in
4
conditions
Dr. Prateek B. Sharma
Interventional Cardiology | Cardiology
Expertise in
4
conditions
Dr. Prateek B. Sharma
Interventional Cardiology | Cardiology
Referral may be required
Before you request

UChicago Medicine Duchossois Center For Advanced Medicine - Hyde Park

5758 S. Maryland Ave., 
Chicago, IL 
 (24.4 miles away)
888-824-0200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Prateek Sharma is an Interventional Cardiologist and a Cardiologist practicing medicine in Chicago, Illinois. Dr. Sharma is highly rated in 4 conditions, according to our data. His clinical expertise encompasses COVID-19, Gastroesophageal Junction Cancer, Gallbladder Disease, Endoscopy, and Colonoscopy. Dr. Sharma is board certified in Cardiovascular Disease Internal Medicine. Dr. Sharma is currently accepting new patients.

Frequently Asked Questions about Dr. Mark J. Ricciardi

How do I make an appointment with Dr. Mark J. Ricciardi?

You can book an appointment with Dr. Mark J. Ricciardi by calling their office at 847-570-2450. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark J. Ricciardi a top-rated expert for Mitral Valve Regurgitation?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark J. Ricciardi is classified as an Distinguished expert for Mitral Valve Regurgitation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark J. Ricciardi specialize in?

While Dr. Mark J. Ricciardi is a Interventional Cardiology, they have specific expertise in Mitral Valve Regurgitation, Aortic Valve Stenosis, and Aortic Valve Replacement. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Interventional Cardiology.

Does Dr. Mark J. Ricciardi participate in research or clinical trials?

Yes. Dr. Mark J. Ricciardi has published 56 articles and abstracts on conditions like Mitral Valve Regurgitation. You can view a list of Dr. Mark J. Ricciardi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark J. Ricciardi accept my insurance?

Dr. Mark J. Ricciardi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 847-570-2450 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ricciardi's expertise for a condition
ConditionClose
    View All 8 Distinguished Conditions
    View All 15 Advanced Conditions
    View All 39 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile